Group One Trading
KYMR icon

Group One Trading’s Kymera Therapeutics KYMR Stock Holding History

Group One Trading’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-200
Closed -$11.3K – 8683
2025
Q3 		$11.3K Sell
200
-2,000
-91% -$90.2K ﹤0.01% 7096
2025
Q2 		$96K Buy
+2,200
New +$75.8K ﹤0.01% 5008
2025
Q1 		– Sell
-500
Closed -$20.1K – 8006
2024
Q4 		$20.1K Buy
+500
New +$22.6K ﹤0.01% 5684
2023
Q2 		– Sell
-6,500
Closed -$193K – 7948
2023
Q1 		$193K Sell
6,500
-26,900
-81% -$868K ﹤0.01% 3714
2022
Q4 		$834K Buy
33,400
+24,700
+284% +$659K ﹤0.01% 2591
2022
Q3 		$189K Buy
+8,700
New +$229K ﹤0.01% 4199

Other funds holding KYMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Group One Trading's KYMR Position: Q4 2022 in Review

Group One Trading sold out of Kymera Therapeutics (KYMR) in Q4 2022, closing a stake of 6,770 shares — an estimated $181K sold.

Group One Trading first reported a position in KYMR in Q1 2022 and held it in 2 quarters. The position peaked at $147K in Q3 2022. 121 funds tracked by Wall St. Rank hold KYMR as of Q4 2022.

  • Group One Trading reported no remaining Kymera Therapeutics position as of Q4 2022 after selling out during the quarter.
  • Group One Trading sold 6,770 Kymera Therapeutics shares in Q4 2022, an estimated $181K.
  • Group One Trading first reported a position in Kymera Therapeutics in Q1 2022 and held it in 2 quarters.
  • Group One Trading's Kymera Therapeutics position peaked at $147K in Q3 2022.
  • 121 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q4 2022.

Based on Group One Trading's 13F filing for Q4 2022, filed 9 Feb 2023.